Navigation Links
John Theurer Cancer Center among first clinical trial sites to join landmark MMRF study
Date:9/20/2011

September 20, 2011, Hackensack, N.J. The John Theurer Cancer Center at Hackensack University Medical Center, a top 50 U.S. News best hospital for cancer, is one of the first four clinical sites enrolling patients in a landmark study designed to uncover the molecular segments and variations of multiple myeloma. The study is the centerpiece of the Multiple Myeloma Research Foundation's (MMRF) Personalized Medicine Initiative, CoMMpass (Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile), aimed to accelerate translational research into therapeutic breakthroughs for patients.

"Over the past decade the multiple myeloma community has made significant progress developing therapies that extend survival and improve quality of life," said David S. Siegel, M.D., Ph.D., Chief, Multiple Myeloma, John Theurer Cancer Center and a Principal Investigator of the study, "This study is designed to build upon our most recent discovery the completion of the first genomic portrait of multiple myeloma. We hope to gain a greater understanding of the mechanisms of the disease to develop personalized treatments for our patients."

The study will enroll at least 1,000 newly diagnosed multiple myeloma patients who have not yet initiated therapy for their disease. Researchers will track patients from initial diagnosis through their course of treatment, over a minimum of 5 years, and conduct sequential tissue sampling to identify how a patient's molecular profile may affect his or her clinical progression and individual response to treatment.

"The John Theurer Cancer Center is committed to participating in clinical trials that may contribute to the development of more targeted treatments for patients," said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., Chief Innovations Officer and Professor and Vice President of Cancer Services, John Theurer Cancer Center. "We are pleased to collaborate with the MMRF on this important research initiative."


'/>"/>

Contact: Amy Leahing
amy.leahing@zibbel.com
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

Related medicine news :

1. Lymphoma Research Foundation and John Theurer Cancer Center collaborate for Lymphoma Rounds program
2. John Theurer Cancer Center and the Promise Foundation partner to offer free skin cancer screenings
3. The John Theurer Cancer Center to host Seventh Annual Neuro-Oncology Symposium
4. John Theurer Cancer Center first in New Jersey to offer complete capabilities of Provenge
5. The MMRF and John Theurer Cancer Center to host patient symposium
6. John Theurer Cancer Center orthopedic oncologist shares new limb sparing surgical techniques
7. John Theurer Cancer Center to host Eighth Annual Northern New Jersey Breast Cancer Conference
8. Oncology basic research director at John Theurer Cancer Center continues transplantation research
9. John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
10. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
11. John Theurer Cancer Center to present innovative research at 2 surgical meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, a ... cells and other difficult to transfect cells, announces its launch of the PluriQ™ ... Gene Editing System is a complete system for culturing and transfecting human ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
Breaking Medicine Technology: